BioGaia AB Interim report 1 January – 30 June 2019

Published on Aug 08, 2019 at 08:00 CET

Comments from the CEO: “Sales in the second quarter increased by 11% (excluding foreign exchange effects, 5%) compared to the...

Lactobacillus reuteri only probiotic mentioned in article on colic in the New York Times: “We know that those drops can help,” says Dr Marc Rhoads

Published on Jul 03, 2019 at 10:50 CET

The article “All Babies Cry, but How Much Is Too Much?” in the New York Times Parenting Section explains what...

Published on Jul 02, 2019 at 08:00 CET

BioGaia has signed an agreement with Abbott LatAm for the exclusive rights to sell BioGaia products under the BioGaia brand...

Published on Jun 24, 2019 at 11:00 CET

BioGaia has been informed by Annwall & Rothschild Investments AB (A & R AB), main shareholders in BioGaia, that they...

Published on May 17, 2019 at 15:18 CET

BioGaia’s CEO Isabelle Dueller has been interviewed by the Swedish financial newspaper Dagens Industri. Click at the following...

Published on May 09, 2019 at 08:00 CET

The Annual General Meeting of BioGaia AB (publ) on 8 May 2019 voted, among other things, to approve the following...

Published on May 08, 2019 at 08:00 CET

Comments from the CEO: Sales during the first quarter increased by 9% (excluding foreign exchange effects, 2%) compared to the...

Published on May 06, 2019 at 13:00 CET

A randomized, double-blind, placebo-controlled study with BioGaia’s probiotic strain Lactobacillus reuteri ATCC PTA 4659 was shown to...

Published on May 03, 2019 at 08:00 CET

The USA will be the first market to launch BioGaia’s new product for bone health, BioGaia Osfortis. The product...